药品注册申请号:209382
申请类型:ANDA (仿制药申请)
申请人:ENDO OPERATIONS
申请人全名:ENDO OPERATIONS LTD
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 TREPROSTINIL TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 1MG/ML No No AP 2019/09/24 2019/09/24 Prescription
002 TREPROSTINIL TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 2.5MG/ML No No AP 2019/09/24 Prescription
003 TREPROSTINIL TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 5MG/ML No No AP 2019/09/24 Prescription
004 TREPROSTINIL TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 10MG/ML No No AP 2019/09/24 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2022/10/27 SUPPL-4(补充) Approval Labeling STANDARD
2019/09/24 ORIG-1(原始申请) Approval STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:TREPROSTINIL 剂型/给药途径:INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 规格:1MG/ML 治疗等效代码:AP
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
021272 001 NDA REMODULIN TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 1MG/ML Prescription Yes Yes AP 2002/05/21 UNITED THERAP
203649 001 ANDA TREPROSTINIL TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 1MG/ML Prescription No No AP 2017/11/30 SANDOZ
209382 001 ANDA TREPROSTINIL TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 1MG/ML Prescription No No AP 2019/09/24 ENDO OPERATIONS
206648 001 ANDA TREPROSTINIL TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 1MG/ML Prescription No No AP 2019/09/26 TEVA PHARMS USA
210214 001 ANDA TREPROSTINIL TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 1MG/ML Prescription No No AP 2020/05/22 DR REDDYS
211574 001 ANDA TREPROSTINIL TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 1MG/ML Prescription No No AP 2021/02/11 ALEMBIC GLOBAL
活性成分:TREPROSTINIL 剂型/给药途径:INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 规格:2.5MG/ML 治疗等效代码:AP
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
021272 002 NDA REMODULIN TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 2.5MG/ML Prescription Yes Yes AP 2002/05/21 UNITED THERAP
203649 002 ANDA TREPROSTINIL TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 2.5MG/ML Prescription No No AP 2017/11/30 SANDOZ
209382 002 ANDA TREPROSTINIL TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 2.5MG/ML Prescription No No AP 2019/09/24 ENDO OPERATIONS
206648 002 ANDA TREPROSTINIL TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 2.5MG/ML Prescription No No AP 2019/09/26 TEVA PHARMS USA
210214 002 ANDA TREPROSTINIL TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 2.5MG/ML Prescription No No AP 2020/05/22 DR REDDYS
211574 002 ANDA TREPROSTINIL TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 2.5MG/ML Prescription No No AP 2021/02/11 ALEMBIC GLOBAL
活性成分:TREPROSTINIL 剂型/给药途径:INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 规格:5MG/ML 治疗等效代码:AP
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
021272 003 NDA REMODULIN TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 5MG/ML Prescription Yes Yes AP 2002/05/21 UNITED THERAP
203649 003 ANDA TREPROSTINIL TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 5MG/ML Prescription No No AP 2017/11/30 SANDOZ
209382 003 ANDA TREPROSTINIL TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 5MG/ML Prescription No No AP 2019/09/24 ENDO OPERATIONS
206648 003 ANDA TREPROSTINIL TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 5MG/ML Prescription No No AP 2019/09/26 TEVA PHARMS USA
210214 003 ANDA TREPROSTINIL TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 5MG/ML Prescription No No AP 2020/05/22 DR REDDYS
211574 003 ANDA TREPROSTINIL TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 5MG/ML Prescription No No AP 2021/02/11 ALEMBIC GLOBAL
活性成分:TREPROSTINIL 剂型/给药途径:INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 规格:10MG/ML 治疗等效代码:AP
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
021272 004 NDA REMODULIN TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 10MG/ML Prescription Yes Yes AP 2002/05/21 UNITED THERAP
203649 004 ANDA TREPROSTINIL TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 10MG/ML Prescription No No AP 2017/11/30 SANDOZ
209382 004 ANDA TREPROSTINIL TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 10MG/ML Prescription No No AP 2019/09/24 ENDO OPERATIONS
206648 004 ANDA TREPROSTINIL TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 10MG/ML Prescription No No AP 2019/09/26 TEVA PHARMS USA
210214 004 ANDA TREPROSTINIL TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 10MG/ML Prescription No No AP 2020/05/22 DR REDDYS
211574 004 ANDA TREPROSTINIL TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 10MG/ML Prescription No No AP 2021/02/11 ALEMBIC GLOBAL
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database